Gene expression analysis of lung adenocarcinoma and matched adjacent non-tumor lung tissue

Tumori

Volumn 100, Issue 3, 2014, Pages 338-345

  Zhang, Wenmei ^a   Gong, Wei ^a   Ai, Hua ^a   Tang, Jie ^a   Shen, Ce ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Coexpression network; Differentially expressed gene; Function and pathway enrichment analysis; Lung adenocarcinoma

Indexed keywords

CELL CYCLE PROTEIN 20; CYCLIN B2; HLA DR ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN 2; MINICHROMOSOME MAINTENANCE PROTEIN 4; SECURIN; CCNB2 PROTEIN, HUMAN; CDC20 PROTEIN, HUMAN; CDC45 PROTEIN, HUMAN; CELL CYCLE PROTEIN; FEN1 PROTEIN, HUMAN; FLAP ENDONUCLEASE; MCM2 PROTEIN, HUMAN; MCM4 PROTEIN, HUMAN;

ARTICLE; AURKA GENE; C1QA GENE; C1QB GENE; C1QC GENE; CANCER DIAGNOSIS; CAV1 GENE; CAV2 GENE; CCNB2 GENE; CDC20 GENE; CDC45 GENE; CELL CYCLE; COL1A1 GENE; COL1A2 GENE; COL3A1 GENE; CONTROLLED STUDY; DNA MICROARRAY; DNA REPLICATION; DOWN REGULATION; EARLY DIAGNOSIS; FEN1 GENE; GENE; GENE EXPRESSION; GENE EXPRESSION ASSAY; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HLA DRA GENE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MCM2 GENE; MCM4 GENE; MICROARRAY ANALYSIS; PTTG1 GENE; UPREGULATION; ADENOCARCINOMA; ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LUNG; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED;

ADENOCARCINOMA; ADULT; AGED; CDC20 PROTEINS; CELL CYCLE PROTEINS; CYCLIN B2; FEMALE; FLAP ENDONUCLEASES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, CDC; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 2; MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 4;

EID: 84921650435     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/1578.17222     Document Type: Article

References (35)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin, 61: 69-90, 2011.
2. Mulshine JL, Sullivan DC: Lung cancer screening. New Engl J Med, 352: 2714-2720, 2005. (Pubitemid 41007826)
3. Williams M, Sandler A: The epidemiology of lung cancer. In: Thoracic Oncology, Ettinger D (Ed), pp 31-52, Springer, New York, 2001.
4. Subramanian J, Govindan R: Lung cancer in never smokers: a review. J Clin Oncol, 25: 561-570, 2007. (Pubitemid 350002964)
5. Kenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA: Comparison of aspects of smoking among the four histological types of lung cancer. Tob Control, 17: 198-204, 2008.
6. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC: World Health Organization classification of tumors: pathology and genetics of tumors of the lung, pleura, thymus and heart. IARC Press, Lyon, France, 2004.
7. Inoue M, Hiyama K, Nakabayashi K, Morii E, Minami M, Sawabata N, Shintani Y, Nakagiri T, Susaki Y, Maeda J: An accurate and rapid detection of lymph node metastasis in nonsmall cell lung cancer patients based on one-step nucleic acid amplification assay. Lung Cancer, 78: 212-218, 2012.
8. Mphahlele RP: Molecular evaluation of ribosomal protein L9 and lipoic acid synthetase genes and in lung and apoptosis. Dissertation submitted to the Faculty of Science, University of the Witwatersrand, Johannesburg, South Africa, 2011.
9. Gordon GJ, Jensen RV, Hsiao LL, Gullans SR, Blumenstock JE, Ramaswamy S, Richards WG, Sugarbaker DJ, Bueno R: Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res, 62: 4963-4967, 2002. (Pubitemid 34984420)
10. Gyöngyi Z, Budán F, Szabó I, Ember I, Kiss I, Krempels K, Somlyai I, Somlyai G: Deuterium depleted water effects on survival of lung cancer patients and expression of Kras, Bcl2, and Myc genes in mouse lung. Nutr Cancer, 65: 240- 246, 2013.
11. Pastorino U: Lung cancer screening. Br J Cancer, 102: 1681- 1686, 2010.
12. Selamat SA, Chung BS, Girard L, Zhang W, Zhang Y, Campan M, Siegmund KD, Koss MN, Hagen JA, Lam WL: Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res, 22: 1197-1211, 2012.
13. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D, Altman RB: Missing value estimation methods for DNA microarrays. Bioinformatics, 17: 520-525, 2001. (Pubitemid 32600498)
14. Fujita A, Sato J, Rodrigues L, Ferreira C, Sogayar M: Evaluating different methods of microarray data normalization. BMC Bioinformatics, 7: 469, 2006.
15. Smyth GK: Limma: linear models for microarray data. In: Bioinformatics and computational biology solutions using R and Bioconductor, Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S (Eds), pp 397-420, Springer, 2005.
16. Dudoit S, Popper Shaffer J, Boldrick JC: Multiple hypothesis testing in microarray experiments. Stat Sci, 18: 71-103, 2003. (Pubitemid 41461823)
17. Chang Y, Fu-De F: Data analysis in microarray experiment. Chin Bull Life Sci, 1: 41-48, 2004.
18. Montero-Conde C, Martin-Campos J, Lerma E, Gimenez G, Martinez-Guitarte J, Combalia N, Montaner D, Matias- Guiu X, Dopazo J, de Leiva A: Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information. Oncogene, 27: 1554-1561, 2007. (Pubitemid 351347876)
19. Clements M, van Someren EP, Knijnenburg TA, Reinders MJ: Integration of known transcription factor binding site information and gene expression data to advance from coexpression to co-regulation. Genomics Proteomics Bioinformatics, 5: 86-101, 2007. (Pubitemid 47430310)
20. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P: The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res, 39: D561-D568, 2011.
21. Sherman BT, Lempicki RA: Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res, 37: 1-13, 2009.
22. Da Wei Huang BTS, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 4: 44-57, 2009.
23. Zhang B, Kirov S, Snoddy J: WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res, 33: W741-W748, 2005. (Pubitemid 44530021)
24. Duncan D, Prodduturi N, Zhang B: WebGestalt2: an updated and expanded version of the Web-based Gene Set Analysis Toolkit. BMC Bioinformatics, 11: P10, 2010.
25. Ondrusova M, Muzik J, Hunakova L, Belohorska B, Tomek D, Ondrus D, Kavcova E: Trends in the lung cancer incidence and mortality in the Slovak and Czech Republics in the contexts of an international comparison. Clin Transl Oncol, 14: 659-666, 2012.
26. Hunter T, Pines J: Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell, 79: 573, 1994.
27. Huang C, Sloan EA, Boerkoel CF: Chromatin remodeling and human disease. Curr Opin Genet Dev, 13: 246-252, 2003. (Pubitemid 36645087)
28. Baldi A, De Luca A, Esposito V, Campioni M, Spugnini EP, Citro G: Tumor suppressors and cell-cycle proteins in lung cancer. Patholog Res Int, 2011: 605042, 2011.
29. Stav D, Bar I, Sandbank J: Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma. Int J Biol Markers, 22: 108-113, 2007. (Pubitemid 47062215)
30. Kidokoro T, Tanikawa C, Furukawa Y, Katagiri T, Nakamura Y, Matsuda K: CDC20, a potential cancer therapeutic target, is negatively regulated by p53. Oncogene, 27: 1562- 1571, 2007.
31. Ouellet V, Guyot MC, Le Page C, Filali-Mouhim A, Lussier C, Tonin PN, Provencher DM, Mes-Masson AM: Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer. Int J Cancer, 119: 599-607, 2006. (Pubitemid 43955714)
32. Ramnath N, Hernandez FJ, Tan DF, Huberman JA, Natarajan N, Beck AF, Hyland A, Todorov IT, Brooks JS, Bepler G: MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. J Clin Oncol, 19: 4259-4266, 2001. (Pubitemid 33081644)
33. Rehfeld N, Geddert H, Atamna A, Rohrbeck A, Garcia G, Kliszewski S, Neukirchen J, Bruns I, Steidl U, Fenk R: The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer. J Carcinog, 5: 4, 2006.
34. Kikuchi J, Kinoshita I, Shimizu Y, Kikuchi E, Takeda K, Aburatani H, Oizumi S, Konishi J, Kaga K, Matsuno Y: Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer. Lung Cancer, 72: 229-237, 2011.
35. Yang M, Guo H, Wu C, He Y, Yu D, Zhou L, Wang F, Xu J, Tan W, Wang G: Functional FEN1 polymorphisms are associated with DNA damage levels and lung cancer risk. Hum Mutat, 30: 1320-1328, 2009.